Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease

James A. Solomon; Michael Oswalt; Michael Nodzenski; Julie Glener; Matthew R. Schaeffer; Todd V. Cartee; Ian A. Maher; Joseph F. Sobanko; Abigail Waldman; Simon S. Yoo; Suzanna Lewis; Morgan Barr; Molly Marous; Brigitte Sledge; Jodi Kay Duke; April W. Armstrong; Emily Poon; Emir Veledar; Robert P. Dellavalle; Murad Alam

doi:10.1097/DSS.0000000000001865

Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease

James A. Solomon, Michael Oswalt, Michael Nodzenski, Julie Glener, Matthew R. Schaeffer, Todd V. Cartee, Ian A. Maher, Joseph F. Sobanko, Abigail Waldman, Simon S. Yoo, Suzanna Lewis, Morgan Barr, Molly Marous, Brigitte Sledge, Jodi Kay Duke, April W. Armstrong, Emily Poon, Emir Veledar, Robert P. Dellavalle, Murad Alam

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

BACKGROUNDRecent increase in skin biopsies has been attributed to an epidemic of skin cancer. This may be avoidable, with potential savings.OBJECTIVETo determine whether the increase in skin biopsies is attributable to increasing frequency of biopsies associated with histology lacking pathological cutaneous disease. Pathological cutaneous disease was defined as (1) a malignancy, precancerous lesion, or lesion of uncertain behavior; or (2) disease symptomatic or associated with adverse quality of life impact.PATIENTS AND METHODSRetrospective cohort study, 2006 to 2013 of dermatology practice serving Florida and Ohio. Data were a consecutive sample of skin biopsies for diagnosis of dermatologic disease.RESULTSA total of 267,706 biopsies by an average of 52 providers per month from January 06 to December 13 were analyzed. Number of biopsies per visit increased 2% per year (RR: 1.02, CI: 1.00-1.04). Likelihood of biopsy associated with histology indicative of nonpathological cutaneous disease did not increase over time (OR: 0.99, CI: 0.95-1.03, p =.6302).CONCLUSIONRates of biopsies associated with nonpathological cutaneous disease is not increasing. Overall biopsy rates per visit have gradually increased; this seems attributable to greater rates of detection of pathological dermatologic disease.

Original language	English (US)
Pages (from-to)	640-649
Number of pages	10
Journal	Dermatologic Surgery
Volume	45
Issue number	5
DOIs	https://doi.org/10.1097/DSS.0000000000001865
State	Published - May 1 2019

Bibliographical note

Publisher Copyright:
© 2019 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.

Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1097/DSS.0000000000001865

Find It

Find It at U of M Libraries

Cite this

Solomon, J. A., Oswalt, M., Nodzenski, M., Glener, J., Schaeffer, M. R., Cartee, T. V., Maher, I. A., Sobanko, J. F., Waldman, A., Yoo, S. S., Lewis, S., Barr, M., Marous, M., Sledge, B., Duke, J. K., Armstrong, A. W., Poon, E., Veledar, E., Dellavalle, R. P., & Alam, M. (2019). Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease. Dermatologic Surgery, 45(5), 640-649. https://doi.org/10.1097/DSS.0000000000001865

Solomon, JA, Oswalt, M, Nodzenski, M, Glener, J, Schaeffer, MR, Cartee, TV, Maher, IA, Sobanko, JF, Waldman, A, Yoo, SS, Lewis, S, Barr, M, Marous, M, Sledge, B, Duke, JK, Armstrong, AW, Poon, E, Veledar, E, Dellavalle, RP & Alam, M 2019, 'Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease', Dermatologic Surgery, vol. 45, no. 5, pp. 640-649. https://doi.org/10.1097/DSS.0000000000001865

@article{02383aff3ddb49839d29d334cee071f1,

title = "Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease",

abstract = "BACKGROUNDRecent increase in skin biopsies has been attributed to an epidemic of skin cancer. This may be avoidable, with potential savings.OBJECTIVETo determine whether the increase in skin biopsies is attributable to increasing frequency of biopsies associated with histology lacking pathological cutaneous disease. Pathological cutaneous disease was defined as (1) a malignancy, precancerous lesion, or lesion of uncertain behavior; or (2) disease symptomatic or associated with adverse quality of life impact.PATIENTS AND METHODSRetrospective cohort study, 2006 to 2013 of dermatology practice serving Florida and Ohio. Data were a consecutive sample of skin biopsies for diagnosis of dermatologic disease.RESULTSA total of 267,706 biopsies by an average of 52 providers per month from January 06 to December 13 were analyzed. Number of biopsies per visit increased 2% per year (RR: 1.02, CI: 1.00-1.04). Likelihood of biopsy associated with histology indicative of nonpathological cutaneous disease did not increase over time (OR: 0.99, CI: 0.95-1.03, p =.6302).CONCLUSIONRates of biopsies associated with nonpathological cutaneous disease is not increasing. Overall biopsy rates per visit have gradually increased; this seems attributable to greater rates of detection of pathological dermatologic disease.",

author = "Solomon, {James A.} and Michael Oswalt and Michael Nodzenski and Julie Glener and Schaeffer, {Matthew R.} and Cartee, {Todd V.} and Maher, {Ian A.} and Sobanko, {Joseph F.} and Abigail Waldman and Yoo, {Simon S.} and Suzanna Lewis and Morgan Barr and Molly Marous and Brigitte Sledge and Duke, {Jodi Kay} and Armstrong, {April W.} and Emily Poon and Emir Veledar and Dellavalle, {Robert P.} and Murad Alam",

note = "Publisher Copyright: {\textcopyright} 2019 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2019",

month = may,

day = "1",

doi = "10.1097/DSS.0000000000001865",

language = "English (US)",

volume = "45",

pages = "640--649",

journal = "Dermatologic Surgery",

issn = "1076-0512",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease

AU - Solomon, James A.

AU - Oswalt, Michael

AU - Nodzenski, Michael

AU - Glener, Julie

AU - Schaeffer, Matthew R.

AU - Cartee, Todd V.

AU - Maher, Ian A.

AU - Sobanko, Joseph F.

AU - Waldman, Abigail

AU - Yoo, Simon S.

AU - Lewis, Suzanna

AU - Barr, Morgan

AU - Marous, Molly

AU - Sledge, Brigitte

AU - Duke, Jodi Kay

AU - Armstrong, April W.

AU - Poon, Emily

AU - Veledar, Emir

AU - Dellavalle, Robert P.

AU - Alam, Murad

N1 - Publisher Copyright: © 2019 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - BACKGROUNDRecent increase in skin biopsies has been attributed to an epidemic of skin cancer. This may be avoidable, with potential savings.OBJECTIVETo determine whether the increase in skin biopsies is attributable to increasing frequency of biopsies associated with histology lacking pathological cutaneous disease. Pathological cutaneous disease was defined as (1) a malignancy, precancerous lesion, or lesion of uncertain behavior; or (2) disease symptomatic or associated with adverse quality of life impact.PATIENTS AND METHODSRetrospective cohort study, 2006 to 2013 of dermatology practice serving Florida and Ohio. Data were a consecutive sample of skin biopsies for diagnosis of dermatologic disease.RESULTSA total of 267,706 biopsies by an average of 52 providers per month from January 06 to December 13 were analyzed. Number of biopsies per visit increased 2% per year (RR: 1.02, CI: 1.00-1.04). Likelihood of biopsy associated with histology indicative of nonpathological cutaneous disease did not increase over time (OR: 0.99, CI: 0.95-1.03, p =.6302).CONCLUSIONRates of biopsies associated with nonpathological cutaneous disease is not increasing. Overall biopsy rates per visit have gradually increased; this seems attributable to greater rates of detection of pathological dermatologic disease.

AB - BACKGROUNDRecent increase in skin biopsies has been attributed to an epidemic of skin cancer. This may be avoidable, with potential savings.OBJECTIVETo determine whether the increase in skin biopsies is attributable to increasing frequency of biopsies associated with histology lacking pathological cutaneous disease. Pathological cutaneous disease was defined as (1) a malignancy, precancerous lesion, or lesion of uncertain behavior; or (2) disease symptomatic or associated with adverse quality of life impact.PATIENTS AND METHODSRetrospective cohort study, 2006 to 2013 of dermatology practice serving Florida and Ohio. Data were a consecutive sample of skin biopsies for diagnosis of dermatologic disease.RESULTSA total of 267,706 biopsies by an average of 52 providers per month from January 06 to December 13 were analyzed. Number of biopsies per visit increased 2% per year (RR: 1.02, CI: 1.00-1.04). Likelihood of biopsy associated with histology indicative of nonpathological cutaneous disease did not increase over time (OR: 0.99, CI: 0.95-1.03, p =.6302).CONCLUSIONRates of biopsies associated with nonpathological cutaneous disease is not increasing. Overall biopsy rates per visit have gradually increased; this seems attributable to greater rates of detection of pathological dermatologic disease.

UR - http://www.scopus.com/inward/record.url?scp=85065391327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065391327&partnerID=8YFLogxK

U2 - 10.1097/DSS.0000000000001865

DO - 10.1097/DSS.0000000000001865

M3 - Article

C2 - 30829782

AN - SCOPUS:85065391327

SN - 1076-0512

VL - 45

SP - 640

EP - 649

JO - Dermatologic Surgery

JF - Dermatologic Surgery

IS - 5

ER -

Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this